Does GHK-Cu have a receptor?

None has been established. The dominant mechanism (copper delivery) does not require one, but the other reported activities are unexplained without it.

Which enzymes does it supply copper to?

Lysyl oxidase, involved in collagen and elastin cross-linking, and superoxide dismutase, which disposes of superoxide radicals, are the two most often named.

Is the copper or the peptide doing the work?

The leading account attributes much of it to copper delivery, which makes the peptide the carrier rather than the active agent. It does not account for all reported effects.

GHK-Cu Mechanism: Copper Delivery and Signalling

The short answer

The dominant mechanistic proposal is copper delivery. GHK acting as a carrier that supplies copper(II) to enzymes requiring it as a cofactor, including lysyl oxidase and superoxide dismutase. Separate reported activities include broad gene-expression modulation. No specific receptor has been established.

Key facts

Primary proposal: Copper delivery to cuproenzymes
Named enzymes: Lysyl oxidase, superoxide dismutase
Also reported: Broad gene-expression modulation
Receptor: None established
Evidence base: Predominantly in vitro
Consequence: Mechanism is inferred, not mapped

Why copper delivery is the leading account

Several enzymes require copper as a cofactor and cannot function without it. Lysyl oxidase cross-links collagen and elastin; superoxide dismutase disposes of superoxide radicals. A molecule that binds copper reversibly and with high affinity is well suited to supplying it, and that framing explains a striking amount of GHK-Cu's reported activity without needing a receptor at all.

What that explains

Reported effects on extracellular matrix biosynthesis fit neatly, since lysyl oxidase is directly involved in collagen and elastin cross-linking. Reported antioxidant activity fits through superoxide dismutase. Both are consequences of enzymes doing their normal job with adequate cofactor rather than of a novel signalling event.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £24.99

What it does not explain

Modulation of thousands of genes is not obviously a copper-delivery effect, and the reported interactions with growth-factor signalling are not either. Either GHK has activity beyond copper transport, or copper availability has consequences broader than the two named enzymes suggest. The literature does not settle which, and both may be partly true.

The missing receptor

No specific GHK receptor has been characterised. That is less damaging here than for a compound like DSIP, because copper delivery provides a coherent mechanism that does not require one. A carrier does not need a receptor to deliver its cargo. But it does mean the non-copper activities are described rather than explained, and cannot be tested by the usual pharmacological methods.

The matrikine framing

GHK is sometimes described as a matrikine. A peptide fragment released from extracellular matrix proteins that signals back to cells. The framing is appealing and connects the compound to matrix biology, but it should be read as a proposed category rather than a demonstrated mechanism, since it too depends on signalling that has not been mapped to a receptor.

How to weigh it

Copper delivery is a plausible, chemically grounded mechanism supported by the compound's most reliable property. That it binds copper. Everything beyond it is more loosely connected. A mechanism that explains part of the literature well and part of it not at all is a normal state for a compound of this age, and it is more useful to say so than to present a unified account the evidence does not support.

Frequently asked questions

Does GHK-Cu have a receptor?: None has been established. The dominant mechanism (copper delivery) does not require one, but the other reported activities are unexplained without it.
Which enzymes does it supply copper to?: Lysyl oxidase, involved in collagen and elastin cross-linking, and superoxide dismutase, which disposes of superoxide radicals, are the two most often named.
Is the copper or the peptide doing the work?: The leading account attributes much of it to copper delivery, which makes the peptide the carrier rather than the active agent. It does not account for all reported effects.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

▸In vitro fibroblast and keratinocyte gene-expression studies
▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
▸Wound-healing scratch assays in cell culture models
▸Antioxidant-mechanism studies (copper redox modulation)
▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

✓Store lyophilised vial at 2–8 °C, protected from light
✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
✓Aliquot reconstituted solution for freeze/thaw minimisation
✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

How we write and check this content Report a factual error in this article

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category.

← Back to Forum

GHK-Cu Mechanism: What Is Actually Proposed